Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Paolo Vignali PhD

Paolo Dario Angelo Vignali PhD

Medical Student, Department of Immunology, University of Pittsburgh School of Medicine and Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania

Paolo Vignali, PhD, is a fourth-year medical student at the University of Pittsburgh School of Medicine. His dissertation research describes how tumor hypoxia interferes with effective immune responses and circumvents immune cell reactivation following checkpoint blockade. Specifically, he has shown how tumor hypoxia accelerates differentiation of effector T cells to a dysfunctional state known as ‘exhaustion’. High levels of exhausted T cells in solid tumors have been shown to correlate with poor outcomes, yet this mechanism remains poorly understood. Paolo advanced this model by demonstrating how hypoxic conditions disrupt metabolic pathways and lead to rapid differentiation of T cells to an exhausted state. Further, he showed that T cells exposed to tumor hypoxia upregulate the inhibitory molecule, CD39, resulting in local suppression of local immune responses. Reversal of tumor hypoxia or deletion of CD39 was sufficient to decrease exhausted T cell concentrations and sensitize treatment refractory tumors to checkpoint blockade therapy. Paolo is currently applying to Dermatology residency programs in the United States and plans to continue to develop his interests in academic research.


Dr. Vignali has no relevant disclosures.